Differentiating hepatitis E from other liver diseases can be a complex process due to overlapping symptoms, but with the right understanding of its clinical presentation, diagnostic methods, and epidemiology, it becomes easier to pinpoint. Hepatitis E can be differentiated from other liver diseases through a combination of clinical presentation, diagnostic testing, epidemiological factors, and unique risk factors. Below are the key points that distinguish hepatitis E from other forms of hepatitis and liver diseases:

Transmission route

Unlike hepatitis B and C, which are primarily transmitted through blood or bodily fluids, hepatitis E is transmitted through contaminated water and fecal-oral routes. This is common in areas with poor sanitation and water quality, such as parts of Asia, Africa, and the Middle East.¹

Acute vs. Chronic infection

Hepatitis E typically causes an acute infection that resolves on its own in healthy individuals, unlike hepatitis B and C, which can become chronic. However, in immunocompromised patients (e.g., organ transplant recipients), hepatitis E can lead to chronic infections.²

Symptoms and severity

Hepatitis E often presents with flu-like symptoms, jaundice, abdominal pain, and loss of appetite. In pregnant women, particularly in the third trimester, hepatitis E can lead to severe complications, such as fulminant hepatic failure (acute liver failure), with a significantly higher mortality rate than other types of hepatitis.³

Liver enzyme levels

Liver enzyme tests (e.g., ALT and AST levels) can help identify liver inflammation, but these are elevated in many liver diseases. What differentiates hepatitis E is that the enzyme levels often return to normal within weeks in uncomplicated cases, unlike chronic hepatitis B and C where elevations persist.⁴

Serological and molecular testing

Specific serological tests can detect antibodies against hepatitis E (anti-HEV IgM for acute infection, anti-HEV IgG for past infection). HEV RNA testing is another molecular method that helps confirm active infection. These tests are crucial in distinguishing hepatitis E from other viral hepatitis infections, as they are specific to HEV.⁵

Lack of vaccine and treatment options

Unlike hepatitis A and B, there is no widely available vaccine for hepatitis E (except in China) and no specific antiviral treatment. Supportive care remains the primary management approach for acute hepatitis E cases.⁷

Hepatitis E may seem similar to other liver diseases at first glance, but subtle differences in its transmission, risk factors, and diagnostic methods help set it apart. Hepatitis E is one of the leading causes of acute viral hepatitis globally, especially in developing countries with poor sanitation. However, due to its similar clinical symptoms and overlapping laboratory findings with other liver diseases, differentiating it from other types of hepatitis (like A, B, C, and D) and non-viral liver conditions (like alcoholic or non-alcoholic liver disease) requires a detailed understanding of its distinguishing features. Here’s how hepatitis E stands apart:

Transmission pathways

Hepatitis E is primarily transmitted through the fecal-oral route, often via contaminated water supplies in regions where sanitation is inadequate. This stands in contrast to hepatitis B and C, which are spread through bloodborne transmission (e.g., through contaminated needles, blood transfusions, or sexual contact). While hepatitis A is also transmitted through the fecal-oral route, hepatitis E tends to be more prevalent in specific geographic locations like Asia, Africa, and parts of the Middle East. In contrast, non-viral liver diseases such as alcoholic liver disease or non-alcoholic fatty liver disease (NAFLD) have no infectious transmission. Instead, they are linked to lifestyle factors, including excessive alcohol consumption, obesity, and metabolic disorders.¹

Clinical Presentation

The clinical symptoms of hepatitis E can closely resemble those of other types of viral hepatitis and liver diseases, including:

• Jaundice (yellowing of the skin and eyes)
• Dark urine
• Fatigue
• Nausea and vomiting
• Abdominal pain, particularly in the upper right quadrant

However, pregnancy is a critical differentiating factor in hepatitis E. Pregnant women, especially those in their third trimester, are at a much higher risk of developing severe liver disease, with a mortality rate as high as 20-30%. This distinguishes hepatitis E from other viral hepatitides, which generally do not show such a severe course during pregnancy.

Acute vs. Chronic nature

Hepatitis E typically results in an acute infection that resolves on its own in most individuals without long-term liver damage. Unlike hepatitis B and C, which can become chronic and lead to long-term liver complications such as cirrhosis or liver cancer, hepatitis E usually does not persist beyond the acute phase. However, in individuals who are immunocompromised, such as those undergoing organ transplantation or those with HIV, hepatitis E can become chronic and lead to severe complications. This chronicity is rare compared to the chronic forms of hepatitis B and C but is significant in the context of immunosuppressed patients.²

Serological and molecular diagnosis

To accurately differentiate hepatitis E from other liver diseases, laboratory tests are crucial:

Anti-HEV IgM and IgG antibodies

The presence of anti-HEV IgM in blood indicates an acute infection, whereas anti-HEV IgG suggests past exposure or recovery. These antibodies are specific to hepatitis E and help distinguish it from other types of viral hepatitis.

HEV RNA Detection

Polymerase Chain Reaction (PCR) tests can detect hepatitis E RNA in the blood or stool, confirming an active infection. This molecular test is particularly useful in immunocompromised individuals where antibody responses might be weak.

Serological and molecular testing is essential because the symptoms and liver enzyme levels (ALT and AST) in hepatitis E may overlap with other liver diseases, making it difficult to rely on clinical presentation alone.⁵

Epidemiology and geographic distribution

One of the defining characteristics of hepatitis E is its geographic distribution. Hepatitis E is more common in regions with poor sanitation infrastructure, such as Southeast Asia, the Middle East, parts of Africa, and Central America. Outbreaks are frequently linked to contaminated drinking water. In contrast, hepatitis B and C are more globally distributed and can be contracted in a variety of settings, often through medical procedures or intravenous drug use.

Hepatitis A, while also linked to sanitation issues, tends to be more prevalent in younger populations and less likely to cause outbreaks with the severity seen in hepatitis E, particularly in pregnant women.⁶

Lack of vaccination and treatment options

Unlike hepatitis A and B, which can be prevented through vaccination, a widely available vaccine for hepatitis E does not exist, except in China. The lack of preventive vaccination makes the disease more challenging to control in at-risk populations. Moreover, there are no specific antiviral treatments for hepatitis E, and care is typically supportive, aimed at managing symptoms and preventing complications, especially in high-risk individuals like pregnant women or immunocompromised patients.⁷

In contrast, hepatitis B and C have effective treatment regimens, including antivirals and immunomodulatory therapies. Non-viral liver diseases, such as alcoholic liver disease and NAFLD, are managed through lifestyle interventions and treating underlying causes.

FAQ’s

Can hepatitis E be chronic?

While hepatitis E is typically an acute infection, it can become chronic in immunocompromised individuals, such as organ transplant recipients or patients with HIV.

Is there a vaccine for hepatitis E?

A vaccine for hepatitis E is available in China, but it is not yet widely accessible globally.

How is hepatitis E treated?

There is no specific antiviral treatment for hepatitis E. Management usually focuses on supportive care, such as hydration and symptom control. In severe cases, especially in pregnant women, close monitoring and intervention may be necessary.

Can hepatitis E cause liver failure?

Yes, particularly in pregnant women in their third trimester and in immunocompromised patients, hepatitis E can lead to severe liver complications, including fulminant hepatic failure.

Summary

In summary, hepatitis E can be distinguished from other liver diseases primarily through its mode of transmission (faecal-oral route), its acute nature in healthy individuals, and the severe complications it presents in pregnant women and immunocompromised patients. Diagnostic tools like serological tests for HEV-specific antibodies and molecular tests for HEV RNA play a crucial role in confirming the infection. Although it shares some clinical features with other viral hepatitis infections, hepatitis E stands apart due to its unique epidemiological patterns, lack of chronicity in most cases, and the absence of a widely available vaccine. In regions with poor sanitation, outbreaks are more likely to occur, making public health interventions critical in controlling the spread of this disease.